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Abstract 
 
The review discusses how the electronic structure of heme explains its central importance to oxygen-
based life on Earth. Emphasis is on the chemical bonding of heme, its spin crossover, reversible O2 
binding, and O−O bond activation, put in relation to its physiological functions. The review discusses 
the spectroscopic and computational data that have helped to elucidate the nature of this remarkable 
molecular system, how it works, and how it is tuned by a range of molecular strategies. This tuning 
enables heme to carry out the two essential functions required for oxygen management of life, i.e. 
reversible oxygen binding for transport and storage, and oxygen activation for use in catalytic processes. 
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1. Introduction 
It is remarkable that the primary biological oxidant on this planet, O2, has a triplet 
3g− ground state with 
two unpaired, parallel-spin electrons due to the quantum mechanical auf-bau principle and Hund's Rule 
applied to its 16 electrons[1][2].  
 Among relevant electron acceptors, oxygen is unique as the atom that, when attached to carbon, 
produces the largest variety of simple, yet diverse organic functional groups. Oxygen is plentiful in water, 
the medium of life that was abundant in the early, reducing atmosphere of Earth. Before the use of water 
as electron donor and oxygen as electron acceptor, hydrogen and sulfur were used in photosynthetic early 
life forms [3]. Thus, previously, O2 was present in much smaller and originally only trace amounts [4][5]. 
However, in the wake of the evolution of oxygenic photosynthesis at least 2 billion years ago in ancestors 
of current-day cyanobacteria [6], O2 is now conveniently available at roughly one fifth of our 
atmosphere's composition, a very visible symptom of the beautiful harmony between the planet's primary 
producers and heterotrophic biomass oxidizers. The transition of O2 from a status as inconvenient 
pollutant or at best, sporadic signaling molecule, to a central role in the major cycles of energy and mass 
is one of the most important events in the history of Earth [7][8][9].  
 Even at the earliest times, organisms had to cope with O2, if nothing else then to prevent its rare 
but dangerous conversion into toxic radicals [8][10]. The evolution of oxygen-managing systems is 
therefore substantially older than the age where O2 rose to prominence [8]. This oxygen management 
system was based on proteins that, sometimes in connection with small anti-oxidant molecules, used 
transition metal ions with unpaired d-electrons to quench the unpaired electrons of oxygen-based 
substrates. Among such systems, the iron-porphyrin cofactor heme is the protagonist [11]. 
 While heme and its various proteins have been the subject of massive scrutiny, this particular 
review will aim at a hopefully new perspective on heme's coordination chemistry and chemical bonding 
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in direct relation to its evolved function as oxygen manager. It may be a comfort to some that indeed 
heme's role in oxygen management is by no means arbitrary [11][12]. To those who already appreciate 
this, the review will hopefully strengthen the appreciation that heme, rather than being just a convenient 
or smart choice, is a superbly fine-tuned molecule in all aspects of its electronic structure, chemical 
bonding, and associated biological functions.  
 The review covers only those specific points that relate directly to electronic structure and 
chemical bonding of heme and its immediate adducts with small ligands, with sad but required (for the 
purpose of focus) neglect of all the interesting chemistry occurring beyond ligand binding: Many 
exquisite reviews deal with such wider aspects of heme chemistry and biochemistry, including the 
general structure and function of the heme proteins [13][14], their stability, oxygen transport and storage 
[15][16], their electron transfer reactions [17][18], the cytochrome c oxidase based respiration [19][20], 
the accomplishments in the field of synthetic heme models [21][22][23][24], catalytic functions of heme 
oxygenases [25][26], heme peroxidases [27], and heme catalases [28][29], cytochrome P450 degradation 
of drugs and other xeno-molecules [30][31], the degradation of the cofactor by heme oxygenase [32], 
and various spectroscopic [29][33] and biological aspects of heme [34][35], including its molecular 
evolution [12][36][37][38].  
 
2. The case for iron 
The element having 26 protons is notable for its abundance: As the main end product of exothermic 
nucleosynthesis of larger stars [39][40], this element makes up most of our planet's core and is Earth's 
most abundant element by mass and the fourth-most common element of the crust [41].  
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 Beyond its abundance, iron is also notable for being in the middle of the first row of the d-block, 
together with manganese. This provides a moderate effective nuclear charge, borderline Lewis acid 
properties [42], and a not too oxophilic, not too thiophilic metal ion that routinely forms complexes with 
both oxygen-, sulfur- [43][44], and nitrogen-donor ligands [45][46]; all three types of ligands to iron are 
encountered in some hemes, a notable example being cytochromes P450 [47]. Once associated with other 
atoms, the richness and modest energy separations of the various electronic configurations of the d-
orbitals produce important degrees of freedom and spin-crossover properties [48]. 
 When iron(III) binds in a weak ligand field of Oh symmetry, it produces a highly paramagnetic 
6A1 state having a half-filled d-shell with only spin-forbidden d-d transitions. However, in a stronger 
ligand field, the weakly Jahn-Teller distorted low-spin state offers rich transitions, as does the iron(II) 
complexes in both weak and strong ligand fields: Such ligand-field transitions of iron in porphyrin were 
familiar to our ancestors as the characteristic red color of blood that largely defines the human 
psychological and cultural connotations of the color representing courage, war, danger, and suffering. 
Incidentally, π-π* transitions within the porphyrin-derived chlorophylls are also responsible for the green 
color of plants, associated with nature, life and hope, so the reader may perhaps agree that porphyrin has 
had vast (but alas! rarely appreciated) cultural consequences.  
 Low-spin iron(II) with six d-electrons is notable for its maximal ligand field stabilization energy 
of 12/5 ∆o in octahedral symmetry. Such complexes are relatively inert in terms of ligand substitution 
reactions, and the fully occupied set of dπ orbitals enable strong back-bonding, a feature that is vital for 
the binding and activation of O2 to be discussed in the following. 
 Iron is also notable for its many potentially available oxidation states, another consequence of its 
position in the middle of the d-block. However, on the surface of Earth, the oxidation states (II) and (III) 
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are most relevant and conveniently close as measured by the standard half reduction potential of iron(III) 
of 0.77 V under acidic conditions, which becomes even smaller at typical biological conditions [49].  
 The iron(II)-iron(III) redox couple can produce fast electron transfer in both high-spin and low-
spin octahedral ligand fields, as the sixth redox-active electron shuffles between low-lying t2g-orbitals 
that point away from the metal-ligand bonds: this minimizes the change in metal-ligand bond lengths 
upon electron transfer and reduces reorganization energies. This advantage of the d5/d6 redox pair is 
unique among biologically available transition metal redox pairs, and the logical alternatives such as 
d3/d4 (e.g. Mn(IV/III)), d4/d5 (e.g. Mn(III/II)), d6/d7 (e.g. Co(III/II)), d7/d8 (e.g. Ni(III/II)) or  d8/d9 (e.g. 
Cu(II/III) or Ni(II)/Ni(I)) or d9/d10 (Cu(II)/Cu(I) all have a change in occupation of the ligand-directed 
d-orbitals in either high-spin or low-spin. Redox couples of d2/d3 and below based on Ti and Cr would 
not suffer such problems but would instead be highly oxophilic and thus not equally suitable. 
Incidentally, this design principle also defines the Td-symmetric iron-sulfur clusters, which are high-spin 
and thus transfer electrons in the low-lying degenerate e level [50][51]. These circumstances are arguably 
a major reason why iron(II/III) is nature's predominant redox couple. 
 
3. The case for porphyrin 
The question why porphyrin evolved to handle oxygen dates back to the time before oxygen was the 
major electron acceptor, to the very origin of life [36], but also relates to photosynthesis based on 
chlorophyll, which, like heme, uses porphyrin [12] and to the corrins that emerged from the same 
uroporphyrinogen III precursor perhaps as early as DNA[36]; corrin's Co−C bond-cleavage-coupled 
carbon rearrangements are involved in the synthesis of DNA parts [52].  Heme is a relatively later stage 
in the synthesis of tetrapyrrole cofactors and most likely evolved two billion years ago [53], still long 
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before the emergence of animals: Ancient heme proteins having the globin fold structure worked as gas 
sensors in archaea and bacteria [54][55]. 
 Several advantages of the porphyrin ligand as the basis of life processes are evident as compiled 
in the following and summarized in Figure 1: 
 (i) First, the high D4h symmetry the central part of porphyrin, porphine, implies a relatively simple 
synthetic pathway based on eight units of δ-aminolevulinate [56][57]. A simple synthesis is plausibly an 
evolutionary advantage and a premise for early use of porphyrin, since the evolution of tetrapyrroles is 
thought to reflect the increasing sophistication of biosynthetic pathways leading ultimately to 
bacteriochlorophylls and hemes [12][58]. This hypothesis has been challenged in some aspects, as the 
more complex biosynthesis of bacteriochlorophyll may have evolved before that of chlorophyll [59]. 
Uroporphyrinogen can be made under relatively simple conditions, i.e. the precursor and common 
ancestor of all major tetrapyrroles may have been available before the biosynthetic routes were 
established [60]. 
 (ii) As a second advantage, the symmetry that eases synthesis of the ligand also imparts it with a 
tetradentate coordination mode that produces high thermodynamic stability of the coordination complex 
formed upon binding to a central metal ion, viz. the chelate effect [61]; without the chelate-afforded 
stability, Fe(II) could be prone to be released, at least in the more labile high-spin state, and in the soluble 
form, it would engage in converting the less toxic hydrogen peroxide into highly reactive hydroxyl 
radicals, viz. the Fenton reaction, Equation (1) [62]: 
 Fe2+(aq) + H2O2 → Fe3+ + HO• + OH−       (1) 
Thus, the tetradentate coordination mode of porphyrin is advantageous to an organism that wants to 
minimize risk of Fe(II) leaking. 
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 (iii) A third advantage of porphyrins is that the equatorial ligand field of porphyrin dampens 
changes in metal-ligand bond lengths, which is very useful in electron transfer reactions where the local 
molecular geometries of the redox partners should ideally change minimally to facilitate high electron 
transfer rates, viz. the reorganization energy of Marcus-Hush theory [63][64][65]. The geometric changes 
that do take place are distributed over a large area, due to the delocalized π-system of the ligand, so that 
reorganization energies become very small for iron porphyrin systems [66][67].  
  
 
Figure 1. The case for porphyrin. The combination of properties that this ligand offers makes it 
uniquely suited for life's most important processes, photosynthesis and O2-management. 
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 (iv) Fourth, the complete π-system of porphyrin produces 26 perfectly delocalized π-electrons 
that fulfil Hückel's 4n + 2 rule of aromaticity [68] and produce a characteristic energy gap between π and 
π* orbitals. The corresponding violet transition at ~400 nm (~3 eV) is known as the Soret (or B) band 
[69]. This transition, upon proper modification as achieved in the chlorophylls, is ideal for harvesting 
photon energy of a magnitude suitable for life: To appreciate this, for a particle in a 1-dimensional box 
to have the first excited state at ~1 eV it must possess a size of ~1 nm, approximately the size of 
porphyrin. Thus, the confined nano-size π-system of porphyrin makes the cofactor a 2-dimensional 
quantum dot, whose excitation properties can be tuned by the substituents on the rings. In addition, 
porphyrin has a second band, called the Q-band. The Soret and Q-bands can be approximated by the 
Gouterman model of the four frontier π-orbitals (two occupied and two unoccupied) [70][71]. As 
exquisite photosensitizers of life, modified porphyrins are now widely investigated for the potential use 
as sensitizer units in man-made solar cells [72][73][74]. 
 The fact that life is largely based on the so-called "visible" part of the electromagnetic spectrum 
is trivial considering that this part borders the UV region of photon energies that spontaneously cleave 
single covalent bonds. A typical carbon-carbon single bond dissociation energy is ~4 eV, and this 
constitutes a fundamental limit for the highest energy that can be harvested without suffering the arbitrary 
photolytic cleavage of typical organic molecules of life. It is notable that porphyrin has its much-studied 
absorption bands at ~400 nm and ~670 nm, intriguingly within ~0.1 eV of the boundary of the visible 
spectrum of humans.  
 (v) A fifth advantage of porphyrin is the fact that the central cavity has a diagonal N−N distance 
of approximately 4 Å (corresponding to closest N−N distances of ~2.83 Å, using Pythagoras' equation). 
This produces a cavity with a size ideally suited for binding different metal ions with high affinity. For 
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the purpose of light harvesting, such metal ions should be closed-shell zinc or magnesium not to quench 
the photo-excitations [75], but with other transition metal ions such as iron(II), which is incorporated 
into protoporhyrin IX in a late step of the heme synthesis [11], the unoccupied d-orbitals quench the 
excitations but instead enable spin-forbidden oxidative chemistry while maintaining the other advantages 
of the ligand system. This profound dichotomy makes porphyrin a cornerstone of both photosynthesis 
and oxidative respiration.  
 (vi)  Sixth, the sp2-hybridized N-donor atoms produce a moderate ligand-field with almost equal 
propensity towards high- and low-spin. This can be seen from the spectrochemical series [76][77], or, 
since this series reflects the absorption band of a series of complexes with variable ligands rather than 
the thermodynamic spin state preference [78], from the recently proposed thermochemical spin 
propensity that takes into account orbital pairing, zero-point energy, and entropy contributions [79]: The 
typical N-donor ligands produce the smallest gaps between high- and low-spin. The particular moderate 
ligand-field strength of the N-donor ligands renders iron porphyrins effective spin crossover (SCO) 
systems [80][81]. The combination of iron and nitrogen is so optimal that the vast majority of SCO 
systems produced in the laboratory by humans are iron complexes with N-donor ligands [48][82].  
 (vii) A seventh notable advantage of porphyrin and related tetrapyrroles is the tunable size of the  
central cavity, which is a remarkable case of molecular co-evolution of ligand and metal ion: Porphyrin's 
cavity is substantially larger than corrin's cavity, which was evolved for low-spin cobalt chemistry [83]. 
Porphyrin fits well the iron(II) and iron(III) low-spin ionic radii but is somewhat too large for cobalt. A 
~0.2 Å reduction in cavity size is characteristic of corrins; this makes a better fit to low-spin cobalt, 
which, due to its increased effective nuclear charge, is smaller than iron for a given oxidation state [66]. 
The fit between ionic radii and cavity contributes to the thermodynamic preference for cobalt with corrin 
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and  iron with porphyrin vs. the opposite alternatives [66] seen from isodesmic substitution reactions 
studied with DFT: 
 CoPorXY + FeCorXY → FePorXY + CoCorXY     (2) 
Por = porphyrin, Cor = corrin, and X and Y represent a variety of axial ligands (including none) [66][84]. 
Such substitution reactions constitute one of the distinct cases where theoretical chemistry can achieve 
chemical accuracy because of the large cancellation of systematic errors[85]. The thermodynamic 
preference of native metal-ligand combinations is a symptom of molecular co-evolution, and one of the 
few examples where such co-evolution can be quantified. Corrin carries a charge of −1 in its deprotonated 
form to encompass the low-spin and low-valent organometallic cobalt chemistry [52]. In practice, this 
was achieved by a specific biosynthetic pathway leading from uroporphyrinogen III, the "common 
ancestor" of all tetrapyrroles, to the corrins, F430, and siroheme, with the other pathway continuing 
towards chlorophylls and the main hemes [86].  
 Incidentally, high-spin iron(II) does not stay within the plane of the porphyrin cavity [84][87]; 
this fitting issue of high-spin vs. low-spin iron is not by itself due to the increased size of high-spin 
states[88], but rather to minimization of the repulsion between the eg-electrons of the high-spin state and 
the N-donor electrons, a repulsion that also gives rise to the longer bonds and deduced larger size of the 
high-spin state; these points were first emphasized by Boyd and co-workers [89][90]. The movement is 
thought to influence the steric-mechanical conversion from tense to relaxed states of hemoglobin upon 
axial O2-binding, as iron moves out of the porphyrin plane upon going high-spin in the deoxy form 
[91][92]. 
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Figure 2. The two most predominant heme variants, Heme A and Heme B. 
 
4. HemeO2: Pauling, Weiss, McClure, and Goddard 
The heme systems contain the porphyrin ring with iron bound and different substituents that define the 
different types of hemes [93][94], the most notable being hemes A and B (Figure 2). The detailed 
electronic structure of heme has been of interest since the co-factor was found in a range of different 
proteins [95]. Heme's use of the porphyrin ligand, with its advantages outlined above, distinguishes it 
from active sites of non-heme iron proteins that use amino acids as ligands, notably by the orbital 
interplay between iron and porphyrin's formidable conjugated π-system, which is absent in any amino 
acid-based ligands [96].  
 Pauling and Coryell [97] first noticed that the adduct of O2 bound to ferrous heme proteins was 
diamagnetic, suggesting that the spins had been inverted during binding; their predicted bent geometry 
of the adduct was later confirmed in model compounds and proteins [23][98]. Immediately, this presented 
a new problem, i.e. how heme facilitates the spin-forbidden binding of ligands so vital to higher life 
forms on Earth. Two prerequisites were needed to elucidate the mechanism behind this process: i) an 
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understanding of the heme-O2 adduct itself, and ii) an understanding of the spin-inversion process 
occurring during O2 binding to heme.  
 The first issue proved controversial: Pauling and Coryell [97] suggested two schemes, one which 
was essentially a neutral O=O binding with two of its electrons to iron to produce a formally iron(II) if 
both the bonding electrons were confined to O2, corresponding to the non-bonding limit of neutral parts, 
but a formally iron(I) if the Fe-O bond were to be considered covalent. The other scheme had a single 
bonded O−O bound with a double bond to iron, i.e. Fe=O−O. From covalent (neutral ligand) counting, 
this would give iron(II) as well, but Pauling and Coryell considered the structure unlikely for "steric 
reasons".  
 In 1960, McClure suggested a valence-bond formulation based on triplet-triplet coupling, which 
is appealing by the low promotion energies required to access these states, rather than the singlet states 
[99]. In 1964, Weiss suggested, based on analogy to chemical reactions in aqueous solution, that the true 
ferrous hemeO2 adduct was mainly of the superoxo-iron(III) type caused by "electron transfer" from iron 
to O2 [100](please note that this discussion dealt only with the formal Fe(II)−O2 bond; the first 
characterization of the formal Fe(III)−O2 bond of ferric heme was only achieved recently [101]). In his 
response to Weiss [102], Pauling maintained the view that the adduct is mainly ferrous in nature, arguing 
for the importance of maintaining oxidation states and the diamagnetic nature of the adduct. 
 Goddard and Olafson suggested an ozone model of the adduct in 1975 which emphasized the 
four-electron three-center bond with maintained triplet state of dioxygen as in the McClure model with 
less electronic reorganization to explain the reversible binding [103]. In 1977, Pauling maintained his 
original view again [104], the same year that Huynh, Case, and Karplus did a first attempt to bridge these 
views by performing early quantum chemical calculations that diplomatically emphasized the importance 
of both Weiss and Pauling resonance forms [105].  
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 The disagreement rested largely on the different views obtained from simple Lewis structures, 
molecular orbitals, and valence bond models, and can be conveniently unified by increased valence 
structures as argued by Harcourt [106] in a comment to the first CASSCF study of the problem by 
Yamamoto and Kashiwagi [107]; Harcourt later summarized these structures [108][109]. What then 
really matters is to pinpoint the electronic structure that accurately reproduces the experimental 
observables and at the same time provides a useful model for further interpretation and prediction.  
 
5. HemeO2: Towards the current consensus 
Various techniques have been helpful in elucidating heme's electronic structure: Vibrational 
spectroscopy provides insight into the strength of the bonds of the heme systems [110][111]. Magnetic 
techniques such as electron paramagnetic resonance (EPR) [112][113], magnetic circular dichroism 
[114], and Mössbauer spectroscopy [115] have been instrumental [116]. The orbitals involved during 
excitation of heme electrons in solution can be described from L-edge resonant inelastic X-ray scattering 
[117]. Many Mössbauer data were measured in the seventies: Deoxyheme has an isomer shift of ~0.9 
±0.05 mm/s [118][119]; but it is much reduced in the O2-heme adduct to ~0.27 ±0.05 mm/s [120], or 
approximately 0.35 mm/s at 0K when accounting for temperature [121]. Recently, mass spectrometry 
has been useful in monitoring ligand binding to heme [122].  
 During the 1990s, computer power and new accurate quantum chemistry methods opened the 
door for much more accurate computational studies of medium-sized molecular systems, including 
tetrapyrroles. Some of the earliest applications of DFT to porhyrins were carried out by Ghosh and co-
workers [123][124], Jones, Hinman, and Ziegler [125], and Kozlowski, Zgierski, and Pulay [126], and 
CASPT2 [127] calculations by Roos and co-workers [128]. Oldfield's group did the first detailed 
theoretical study of Mössbauer parameters affecting electronic structure of heme models [129][130]. 
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Figure 3. The atomic-resolution (R = 1.0 Å) structure of sperm whale myoglobin with O2 bound to 
heme (PDB code 1A6M [131]). O2 binds in a bent form, with a Fe−O−O angle of 122.5º; the Fe−O bond 
length is 1.81 Å, the O−O bond length is 1.24 Å,  and the hydrogen-bonding nitrogen of the distal 
histidine is ~3 Å away from oxygen. 
 
 Some relevant facts that have emerged are i) the O−O bond is substantially weakened compared 
to free O2, its vibrational wave number of 1100 cm
-1 being close to that of superoxide, as first observed 
by Collman's group [110]; ii) the isomer shift of iron substantially decreases from ~0.9 to ~0.3 mm/s 
upon binding O2 in support of partial iron oxidation [115]; iii) the bond is bent as evident now from 
crystal structures of many proteins and heme models, with a notable example of the HemeO2 adduct of 
myoglobin given in Figure 3, based on the crystal structure 1A6M [131]; iv) the adduct is EPR-silent in 
an apparent singlet state [97]; v) the optical excitation spectrum of oxyheme measured by Eaton et al. 
features, in addition to the π-π* bands, two d-d transitions and five transitions of the FeO2 moiety that 
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provide important reference data for an interpretation of the electronic structure [132]. A first attempt to 
describe this spectrum quantitatively was reported by Nakatsuji et al. in 1996 [133].  
 In 2004, the multi-state CASPT2 method [127] by Roos and co-workers in Lund was substantially 
improved to provide accurate correlation energies and electronic absorption spectra of transition metal 
systems [134]. This enabled a multi-configurational description with account of both dynamic and non-
dynamic correlation of the various electronic configurations involved in the Fe−O2 bond thus moving 
beyond the Pauling-Weiss debate based on two different single-configuration states. The problem thus 
seemed ideally suited for the newly improved multi-state CASPT2 method. The electronic experimental 
absorption spectrum and isomer shifts could be modeled accurately, thus capturing for the first time all 
these features in one electronic structure [135].  
 However, interpretation depends on model language, orbital localization, and transformation 
between valence bond and orbital formalisms: In terms of molecular orbital theory, the wave function 
was a multi-configurational state dominated by the Pauling configuration [135]; however, if one uses 
valence bond theory considerations, it can be interpreted as having large Weiss character [136]. Thus, 
the multi-configurational state produced from CASPT2 [135] is interpreted differently by different 
models. This partly explains why the trenches were so deeply dug during the exchange between Pauling, 
Goddard, McClure, and Weiss; all were right, and all were wrong.  
 Later, the groups of Pierloot [137][138][139], Shaik [140][141], and Ghosh [142][143] carried 
the study of hemes by CASPT2 much further. According to Shaik and co-workers, the Weiss form is 
further increased upon polarization effects by condense media and hydrogen bonding [140]. This is 
because such effects will increase the weight of the polar Weiss configuration, in particular if hydrogen 
bond to O2 enables further back-bonding, and DFT is largely consistent with the experimental and high-
level computational data [144]. In terms of valence structures, the ground state was summarized by Shaik 
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and Chen as having contributions from both Weiss, Pauling, and McClure forms, the first being 
dominating [141].  
 Ironically DFT ends up providing a useful language after all [141]: The charge assignments to O2 
are very dependent on calculation scheme, and both the orbitals, valence structures, and atomic charges 
that defined the Weiss-Pauling debate are non-observable. In contrast, the electron density is observable 
as are the geometries and spectroscopic data summarized above. DFT is in agreement with these 
experimental facts (however less accurate for the d-d transitions than multi-state CASPT2) [135]. "DFT" 
covers a wide range of applied functionals that tend to give different quantitative results even if the 
qualitative electronic structure is reasonably similar [85]. This is very much the case also for iron 
porphyrin systems where the gap between spin states and the O2-binding affinity are two critical 
properties that should be accurately modeled [80]; in fact often, a functional that is accurate for one 
property is not for the other of these two [145]. However, if one accounts for the systematic effects of 
zero-point energies and vibrational entropy, which favor high-spin and weakens O2-binding, and 
dispersion and relativistic effects, which favor low-spin and stronger binding, accurate results are 
obtained with the functional TPSSh for both spin gaps and binding enthalpies [80][121][146]. 
 The Fe−O2 bond is explained as follows: The O2 molecule approaches high-spin deoxyheme to 
form a low-spin state; the actual spin transition is described later in this review. The adduct is represented 
by two major movements of electron density, one via the -donation from a lone pair on O2 into the 
bonding region with iron, which reduces electron density formally assigned to O2, and another opposite 
to this via back-bonding into the orthogonal π*-system of O2, which increases charge on O2. The resulting 
adduct has an O−O bond that has been weakened by back-bonding to resemble superoxide, but with 
some charge density having been donated to iron, so that the oxyheme adduct becomes a mixture of 
Weiss and Pauling forms. Available experimental data are consistent with a major role of back-bonding 
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[121][135][147], which is implicit in the "electron transfer" model suggested by Weiss. Finally, the spin 
polarization of the unrestricted singlet configuration obtained from DFT [144] represents an 
approximation to a real state with unpaired electron density in various parts of space, notably in the anti-
bonding π*-system of O2 and on iron, that couples to produce an EPR-silent singlet state. From a strict 
wave function point of view, this DFT singlet is not pure and not complete, but the density, when sculpted 
by an accurate functional, provides accurate observables, e.g. structures, Mössbauer isomer shifts and 
vibration frequencies [146], also for thermochemical energies and barriers to an extent that is not yet 
reported with similar accuracy for CASPT2 or any other method [121]. 
 Back-bonding of d-electrons into the partly filled π* orbitals of the ligand is quite common when 
transition metal ions have available occupied dπ orbitals (dxz, dyz, if the z-axis follows the metal-ligand 
bond) and the ligand has empty or partly filled π* orbitals at an energy comparable to the d-orbitals. As 
a π-acceptor ligand binds more tightly to the metal via its -donation to strengthen the metal-ligand bond, 
it also increases π*-back-bonding to weaken the intra-ligand bond. Vibrational spectroscopy, in particular 
resonance-Raman spectroscopy, has been particularly useful in elucidating the nature of the FeO2 moiety 
with emphasis on this type of back-bonding [147]. 
 Back-bonding is also evident from the effect of distal hydrogen bonds on heme systems [146]. If 
back-bonding is indeed a major factor in determining the electronic structure, hydrogen bonding to a lone 
pair of oxygen should work to increase back-bonding by lowering the energy of the π* and thus increase 
its weight in the total wave function. This is indeed seen and correlates with a consistent tendency of 
reducing isomer shifts and increasing O−O bond lengths and spin densities on iron as the back-bonding 
character increases [146]. 
 Recently, the group of Solomon has studied a synthetic O2-heme adduct with L-edge X-ray 
absorption spectroscopy, which provided a new detailed picture of the orbital interactions involved in 
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the adduct; this may prove a very useful technique in the study of orbital contributions to Fe−O2 bonding 
in various types of heme systems [148].  
 
 
Figure 4. The modulation strategies towards either irreversible O2-activation or reversible O2-
transport in heme proteins. 
 
 
6. Modulation of the electronic structure and function of heme 
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Considering the remarkable ability of heme proteins to engage in distinct types of chemical reactivity 
such as reversible O2 binding, O2-activation and oxygenation of organic substrates, and electron transfer 
processes, it seems likely that the heme cofactors can be modulated to favor one type of reactivity over 
another. There are several ways that heme electronic structure and function can be modulated [23], as 
summarized in Figure 4 and discussed below.  
 First, the substituents defining the different types of hemes already change the properties; 
substituents can be classified as either electron-withdrawing or electron-inducing [147]. A clear example 
of this was provided by Zhuang et al. whose electron-withdrawing formyl substituents in heme A increase 
the reduction potential by 179 mV [93]. Correspondingly, a recent study by Shibata et al. documented 
the effect of electron-withdrawing trifluoromethyl groups on the O2-binding [149].    
 Due to computational cost considerations, most theoretical studies of heme have been conducted 
without side chains; however, the heme side chains withdraw substantial electron density from the iron 
center, to the effect of reducing the isomer shift by ~0.07 mm/s and increasing the Weiss character of the 
Fe−O2 bond [121]. Correspondingly, the experimental isomer shift of 0.92 mm/s for deoxymyoglobin is 
closely reproduced (0.93 mm/s) when side chains are included, but porphyrin without side chains gives 
0.99 mm/s [146]. Thus, the differences in heme substituents affect the significance of Fe(III) vs. Fe(II) 
[93], as shown schematically in Figure 4 as "XHEME SUBSTITUENT".  
 Second, the conformation of the heme ring can be non-planar, and several conformations define 
the structures of heme proteins. These conformations and their respective motions can be categorized 
[22][150]. Such distortion is involved in the metal incorporation step of metalloporphyrin synthesis, as 
first emphasized by Sigfridsson and Ryde [151]. 
 Third, modulations of the properties of the axial ligands and their immediate environment can 
substantially change the properties of heme. Valentine et al. first speculated on such modulation effects 
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based on analysis of crystal structures of heme proteins published in the seventies [14], and Dawson 
discussed several further such relationships [152]. Tezcan, Winkler, and Gray studied the effects of the 
heme environment that can change reduction potentials by several hundred mV [153]. Poulos and Goodin 
debated the role of the axial ligands and hydrogen bonds in modulating the redox potential and catalytic 
function of heme proteins, notably in terms of stabilizing the ferryl intermediate compound I in heme 
enzymes [154][155]. Site-directed mutagenesis is of major importance in evaluating the magnitude and 
direction of modulation effects. In the case of cytochrome c, studies of mutant proteins have enabled a 
detailed understanding of the relationship between amino acid and redox potential [156][157].  
 In the case of chlorophyll, a systematic DFT study by Ryde and co-workers showed how different 
axial ligands were chosen in photosystems to tune the redox potential to prevent back transfer of electrons 
and to also fine-tune excitation wave lengths by up to ~0.25 eV (e.g. 35 nm for the B-band) [158]. In 
substituted porphyrin models the substituents directly affect reactivity [159]. For heme complexes, the 
effect of ligands on the characteristic Q-band at ~550 nm and the Soret (B) band at ~400 nm were 
investigated in substantial detail by Wang and Brinigar; both bands changed by up to ~20 nm as a 
function of ligand, corresponding to approximately 0.15 and 0.08 eV for the Soret and Q band, 
respectively [160].  
 In addition to these three direct modulations, it has also been proposed that electropositive 
hydrogens may interact with the π-system of heme to change its properties [161]. There is also a potential 
issue of the orientation of the axial histidine's imidazole ring, as this ring can be positioned staggered or 
eclipsed with respect to the equatorial Fe-N bonds of heme, and the anisotropy of the imidazole may 
cause a polarization effect in the heme [162]. 
 The most well-known example of protein modulation of heme electronic structure is the 
communication between the four heme groups of hemoglobin [163][164]. Christian Bohr and co-workers 
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first observed the sigmoidal O2 saturation curve of hemoglobin that implies cooperative binding [165]. 
The allosteric mechanism that produces such cooperativity was formulated mathematically by Monod, 
Wyman, and Changeux in 1965 [166], and this cooperativity has since been a highly researched topic 
[163][167][168][169]. Perutz and co-workers emphasized the importance of salt bridges in stabilizing 
the conformations that favored additional binding of O2 and described these two states as the tense and 
relaxed states of hemoglobin [91][92]. The reduction in the iron out-of-plane distance that accompanies 
O2-binding may also effectuate an energy contribution that translates into protein conformational changes 
[91][92].  
 Ivanovíc-Burmazovic and co-workers recently used three synthetic models with variable access 
to the distal coordination site of heme: Accordingly, proteins and artificial scaffolds can be tuned to 
control ligand binding kinetics so that high-pressure effects, which would normally favor the compact 
bound state and retard dissociation rates, can be balanced or even reversed [170]. This may be a necessary 
tuning strategy of heme proteins at high pressure, e.g. in deep-diving mammals: A shift in the equilibrium 
constant KO2 of O2 binding could adversely affect the saturation curves of myoglobin and hemoglobin 
[171]. A survey of myoglobins of deep-diving cetaceans revealed only small differences in KO2, 
suggesting selection pressure to maintain the delicately tuned hemoglobin-myoglobin transport and 
storage system, with binding and release dependent on the variable partial pressure of O2 within the body 
[172]. The vital importance of the quantum-mechanically fine-tuned reversible binding of O2 is 
confirmed by a theoretical analysis of the grave impact on the aerobic dive limit of seals with mutant 
myoglobins having reduced KO2 values [173].  
 DFT turned out to be a powerful tool for testing modulation effects, because systematic errors 
cancel to a high extend in comparisons with and without the "modulation". DFT studies have confirmed 
the substantial axial substitution effects on porphyrin redox potentials [174][175] and on a range of heme-
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related properties important to its chemical functions [176]. Calculations of a series of models of 
myoglobin mutants [146] indicate that hydrogen bonds to O2 has the following general and statistically 
significant effects: i) To increase back-bonding as described above, by favoring the Weiss configuration; 
ii) to consequently lower the strength, increase the length, and activate the O−O bond for potential 
cleavage; iii) to lower Mössbauer isomer shifts reflecting the increased Fe(III) character of the state; iv) 
to increase the O2 binding affinity by hydrogen-bond stabilization of the adduct [146]. These effects 
appear in synthetic models that stabilize the "Weiss" resonance form by explicit hydrogen bonding [177] 
and are summarized in Figure 4 as "XDISTAL". The main structure-spectroscopy correlations that 
document this importance of back-bonding are shown in Figure 5, which summarizes the effect of 
changing the distal amino acid residue of myoglobin models[146]. Berryman et al. also studied the effect 
of different amino acids on the O2-binding energy of heme and also tested the application of range-
separated functionals to these systems [178]. 
 The spin states are important in the reactivity of hemes and have been recognized to be close in 
energy for a long time, as described by Griffith and co-workers [179]. These spin states can also be 
modulated by tuning of axial ligands, as emphasized by Scheidt and co-workers [180][181][182], and 
studied theoretically by Jensen and Ryde [183] and De Visser [184]. Normally, the five-coordinate hemes 
are high-spin whereas the six-coordinate hemes tend to be low-spin [180]; in contrast, the four-coordinate 
iron(II)porphyrin is remarkably in an intermediate spin ground state [185], and due to the solvent 
accessibility of iron's d-orbitals, this spin state is particularly sensitive to solvent effects [85]. In synthetic 
heme model compounds, the spin state can be modulated directly by weak hydrogen-bond interactions 
[186].  
 
7. Dual function of heme proteins by evolved differences in protein polarization 
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In the discussion of the dual heme functions of O2 activation vs. reversible O2 binding, hydrogen bond 
modulation plays a predominant role: Valentine and co-workers first studied hydrogen bonding patterns 
and their effect on heme properties in detail [187]. An important hint came from the observation that 
globins tend to have hydrogen bonds from backbone carbonyl oxygens to the proximal histidine, whereas 
some O2-activating enzymes such as heme peroxidases tend to have hydrogen bonds to a carboxylate 
side chain [183]. DFT calculations identified a significant tendency towards partial deprotonation and 
increased -donation of the proximal histidine in the models with carboxylate, leading to shorter axial 
Fe−N bonds that selectively stabilize the Fe(III) and Fe(IV) states required for the heme enzymes, 
whereas the hydrogen bond to carbonyl oxygen in the globins does not provide the same contribution to 
O−O bond cleavage [183] ("XPROXIMAL" in Figure 4).  
 Perhaps of equal interest, the high- and low-spin states are modulated by the change in ligand 
field strength of the proximal histidine so that the gap is smallest for the iron(II) systems when the 
proximal histidine is neutral, but for the Fe(III) state when the proximal histidine is partially deprotonated 
[183]. Thus, spin crossover and stabilization of relevant oxidation states are both tuned to the desired 
directions by the axial ligand modulation. It is fascinating how natural evolution has led to the fine-tuning 
of this polarization by amino acids to produce two markedly different kinds of chemistry, activation (i.e. 
use) vs. reversible binding (i.e. transport and storage), both essential to a proficient infrastructure of 
oxygen-based life.  
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Figure 5. The importance of back-bonding in heme-O2 adducts with variable distal interactions, 
quantified by structure-spectroscopy correlations deduced from DFT. A) O−O stretch frequency vs. 
O−O bond length; B) Mössbauer isomer shift vs. O−O bond length; C) spin density on distal oxygen 
(oxygen farthest from iron) vs. spin density on iron; D)  Mössbauer isomer shift vs. spin density on iron. 
Copyright 2013, American Chemical Society. The figure was modified relative to the original to 
emphasize the strong and weak back-bonding regimes [146]. 
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Figure 6. The broad-crossing mechanism of ligand binding to heme: Small ligands can bind to 
deoxyheme despite the spin-forbidden nature of these processes and the limited (< 5 kJ/mol) spin-orbit 
coupling; this is essentially due to the evolved topology of the potential energy surfaces of heme with 
extremely close-lying spin states over an extended region of the surface that increases crossover 
probability far beyond that of related systems (the scheme is inspired by a similar scheme in Ref. [121], 
copyright 2013 John Wiley & Sons). 
 
 As an alternative theory of the dual-function modulation of heme proteins, it has been suggested 
that specific protein conformations enforce differences in the structure and function of similar 
tetrapyrrole cofactors, as these distortions may tune the redox potentials and guide the distinct types of 
reactivity [188]. It is likely that both the choice of axial ligands, the hydrogen bonding to immediate 
neighbors, the local environment of the heme, and long-range protein effects contribute to the modulation 
of heme reactivity, as there is no reason why nature should not use all tools at its disposal; the full 
interplay and relative magnitudes of these effects still remain to be elucidated. 
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8. Ligand binding to heme: Forbidden but feasible 
Having outlined the general principles of the electronic structure of the O2-heme adduct and its 
modulation by various strategies, the second fundamental question of concern was: How does the heme 
system facilitate fast and reversible binding of O2, considering the spin-forbidden nature of this process? 
As stated in the beginning of this review, O2 has a triplet ground state, and the first excited singlet state 
is inconveniently at ~1 eV above this ground state [23]. The unpaired electron density of the π* orbitals 
are reluctant to react with organic molecules, partly because of the low spin-orbit coupling of the involved 
atoms and partly because of the high energy of excited singlets of the oxygen species on the 
corresponding potential energy surfaces (PES) of oxidation reactions, which makes the transition states 
energetically inaccessible even if the spin-orbit coupling were moderate.  
 This problem was first studied with DFT methods in the case of CO binding by Harvey who 
established several principles of the process [189]; a few years later, in 2002, Franzen used a 
geometrically fixed model iron porphyrin to calculate the PES of O2 dissociation [190]. Although the 
fixation of the heme geometry leads to errors of up to 100 kJ/mol, the important novelty of Franzen's 
work was the application of Landau-Zener formula [191][192] to the estimation of crossover probabilities 
for a DFT-derived PES of this process. The related photo-dissociation of the O2- and CO-adducts was 
studied by time-dependent DFT by De Angelis et al. in 2003 [193].  
 In 2004, Jensen and Ryde [144] computed the first fully relaxed PES for O2 binding to heme; they 
also applied the Landau-Zener formula and emphasized tuning of crossing probabilities in two ways to 
circumvent the fixed (i.e. non-tunable by natural evolution) spin-orbit coupling: either by the energy 
differences of the involved spin states of the PES, or by the gradient differences of the PES topology. 
Accordingly, spin-forbidden ligand binding was mainly facilitated by allowing the spin states to be close 
in energy at dissociation and association. This remarkably produces a "broad crossing region" which 
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maximizes crossover probability (Figure 6). In other words, by evolving a deoxyheme with close-lying 
electronic states of variable spin, including an excited triplet state at 10 kJ/mol above the quintet ground 
state [194], fast reversible crossing was achieved. This mechanism, referred to as the "broad crossing 
mechanism" [121] remains a useful design principle for spin-forbidden ligand binding to first row 
transition metals where spin orbit coupling is limited to a few kJ/mol [144].  
 In 2012, Ali et al. studied the structure and PES of O2 binding to heme in detail and reported 
under-binding of B3LYP [195], consistent with other findings [85][121]. Because of the potential errors 
due to method choice and neglect of side chains of heme, the full heme with side chains and account for 
dispersion interactions was subsequently studied [121]. The interactions of the side chains with the ligand 
contributes to the PES, and dispersion effects are required to model this process accurately, producing 
first-time agreement with both the experimental barrier of 82 kJ/mol and the enthalpy of binding of −59 
kJ/mol [196] when using the functional TPSSh with D3 dispersion corrections [197] for the full heme 
system [121]. The broad crossing region is obtained both with B3LYP and TPSSh, although the latter 
PES is in better agreement with experimental thermochemical data [121]. 
 It is notable that the close-lying spin states of hemes are evident not only in the globins, but also 
in various states of heme enzymes such as peroxidases and cytochrome P450; the proximity of these spin 
states has induced the proposal of the "two state reactivity" of heme enzymes by Shaik and co-workers 
[198]. The initial spin-forbidden binding of ligand to heme has, as argued above, been the subject of 
substantial evolutionary optimization because this step could otherwise be slow and rate-limiting. 
However, in other steps of the catalytic cycles of heme enzymes, during binding and dissociation of 
ligands to iron, the broad crossing regions are probably still required to facilitate fast reactions. The broad 
crossing mechanism contributes many orders of magnitude to reactivity by facilitating spin inversion 
[121]. In compound I of some heme enzymes, the doublet and quartet states are particularly close in 
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energy due to the antiferromagnetic vs. ferromagnetic coupling of an intermediate spin Fe(IV) with a 
ligand-based radical [199]. This radical delocalization is a further trick used to facilitate oxygen 
activation; the spin states of the resting states are already close in energy due to tuning of the ligand field 
by hydrogen bonds [183]. In this author's opinion, the most important reactivity gain still lies in the 
facilitation of spin inversion by the broad crossing region caused by close-lying spin states that accelerate 
binding rates by orders of magnitude [144], and not so much in the actual contribution of two specific 
states to reactivity (which would roughly double the rate in the simplest case). When O2 binds to 
deoxyheme, there are already two states reacting, i.e. a triplet and quintet coupled to either a heptet or a 
triplet [190]. Neither of these states would be very reactive, given the modest spin orbit coupling of heme 
systems, had it not been for the special evolution of the close-lying quintet and triplet states of deoxyheme 
that produce a PES with a broad crossing region [144].  
 In the proteins, Olson and co-workers have systematically worked to increase our understanding 
of the kinetics and thermodynamics of the ligand binding process, in particular in engineered myoglobin 
mutants [200][201][202]. These studies have added additional insight into the control of the protein in 
directing the ligand to and from the distal heme site. The rates of ligand dissociation and recombination 
measured experimentally in these studies reveal how remarkable effective and reversible these processes 
are. 
 
9. Binding of CO and NO to heme 
Hemes evolved to bind oxygen-based diatomic ligands such as O2, NO, and CO with the distinct bond 
orders 2, 2½, and 3 corresponding to 2, 1, and 0 unpaired electrons in the π* orbitals. This difference (as 
well as the change in proton number by 1 or 2 of the ligand donor atom) influences the way heme binds 
to these three ligands, and these differences have been the subject of substantial scrutiny [203], in 
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particular given the biological roles of all heme-ligand adducts in cellular signaling [204]. Strickland and 
Harvey have studied by DFT the processes of binding of all three ligands, CO, NO, and O2 to heme, 
providing a very useful basis for comparison of the three ligands [205]. 
 The role of the nitric oxide radical as an important signaling molecule in mammals was 
discovered in the eighties and gained wide-spread appreciation in the nineties [206], with the 1998 Nobel 
prize in physiology and medicine awarded to Furchgott, Ignarro, and Murad for this discovery. Heme 
plays a central role in regulating NO, notably by being required for NO synthesis by nitric oxide synthase 
[207]; NO can bind ferrous and ferric forms of the heme group to regulate its own synthesis by negative 
feedback [208].  
 The distinct bonding of NO to heme compared to CO is due to the additional π* electron in NO 
to heme and its notable back-bonding, as studied in detail by Xu and Spiro, [209]. As recently 
summarized by Hunt and Lehnert [210], the electronic structure of the NO adduct is largely responsible 
for its signaling role: In particular, the strong Fe−NO -bond of the ferrous heme adduct in soluble 
guanylate cyclase weakens the trans proximal Fe−N bond and thereby causes a conformational change 
that triggers synthesis of cyclic guanosine monophosphate, an important second messenger and activator 
of kinases. 
 Of similar interest has been the binding of CO to myoglobin, compared to O2. While O2 binds in 
a bent geometry, as expected from a consideration of its lone pair Lewis structure and predicted already 
by Pauling [97], CO is expected to bind linearly due to its sp-hybridized single lone pair on carbon in the 
weak binding limit. However, if bonding is strong, electronic redistribution would enable a bent geometry 
of the CO adduct. CO binds 10,000-fold more strongly to heme than O2 does, a feature that explains why 
CO is toxic to animals in larger amounts, but in the proteins, this selectivity is reduced to ~100 [203]; 
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the nature of the protein's ability to shift the selectivity has been a subject of substantial scrutiny 
[110][111][211][212].  
 Initial structures of the CO-adduct of myoglobin indicating a bent structure inspired the idea of 
Collman et al. that steric strain, i.e. repulsion between electron clouds of CO and near-by distal amino 
acid residues of the protein pocket, forced CO into a non-optimal bent geometry to reduce its binding 
affinity [110]. However, more than twenty structures of synthetic heme CO adducts contain limited 
bending [211]; Olson and Phillips, based on thermochemical data of site-directed mutants, suggested that 
the protein-imposed change in selectivity was mainly due to electrostatics [212]. From vibrational spectra 
and DFT calculations, Spiro and Kozlowski [111] argued against the steric mechanism as the initial 
crystal structures did not actually support a bent structure due to poor resolution in the FeCO region. 
Sigfridsson and Ryde confirmed, based on DFT calculations, that the experimental selectivity between 
O2 and CO binding could be largely described by normal electrostatic polarization effects [213].  
 Finally, a new near-atomic resolution crystal structure of the CO adduct of myoglobin by 
Kachalova et al. showed that CO binds nearly linearly [214], ending the debate on the binding geometry 
of CO once and for all. CO is a strong π-acceptor ligand with enhanced back-bonding properties 
compared to O2; the amount of this back-bonding correlates with the bond strength [111][147]. The 
simplest way for the protein to effectuate such a change in affinity is via polarization effects 
[147][200][213][215]. Now, the CO is more polar, but in particular binds more strongly due to its 
stronger π-acceptor tendency vs. O2. In the light of the bonding described above, it is conceivable that 
less favorably positioned hydrogen bonds from the distal histidine lowers the CO/O2 selectivity as it 
reduces the π-acceptor capabilities of CO. 
 
10. Conclusions 
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The purpose of this review has been to show how fundamental quantum mechanics, in the form of the 
controlled spin-forbidden binding of O2 to heme, plays a dominant role in the evolution and maintenance 
of life as we know it. Without the porphyrin ring, it is hard to imagine how the photoautotrophic life 
forms based on π-π excitations and electron transfer to harvest the photon energy of our near-by yellow 
G-star could have ever been united with the need for exquisite O2-managing carried out by heme; as it 
is, we now know that all the three defining features of photosensitizing, electron transfer, and spin 
crossover are present within the very same porphyrin ring. This is an outstanding achievement of such a 
simple molecular system, and without it none of this, including this review and its reading, would 
probably have ever occurred.  
 The spin crossover nature of the moderate ligand field of heme, evident from its close-lying 
excited spin states [194], enables fast inversion of spin as required for routine O2 binding as emphasized 
by the broad crossing mechanism. The back-bonding into the O−O bond, tuned by multiple strategies of 
the heme protein, determines the nature of O2 management: A moderate back-bonding to O2 produces 
relatively weak and reversible binding, as fit for transport and occasional storage; this type of bonding is 
achieved in the ingenious O2 transport-storage system constituted by myoglobin and hemoglobin. In 
contrast, strong back-bonding is facilitated by hydrogen-bonding to the O2 or by electrostatic polarization 
of the proximal ligand to favor the high-valent resonance forms of iron. Without heme and its intriguing 
dual abilities of O2-transport and activation, O2 could probably not have been used to the extent that we 
know today. 
 There was rarely an example clearer than this of the direct reliance of life as we know it on the 
almost miraculous quantum mechanical properties of a single molecular system. The binding of O2 to 
heme is a truly quantum mechanical phenomenon with vast consequences for life, not just in terms of 
immediate suffocation if this spin crossover disappeared but also, in a larger context, in the ability to use 
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O2 as the main electron acceptor of the energy-rich electrons of organic matter that define heterotrophic 
life on this planet.  
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